Swiss Nanoscience Institute

Swiss Nanoscience Institute
Swiss Nanoscience Institute · CC BY-SA 4.0 · source
Name	Swiss Nanoscience Institute
Established	2001
Location	Porrentruy, Canton of Jura, Switzerland
Type	Research institute
Director	(see Organization and Governance)
Affiliations	University of Basel, ETH Zurich, EPFL, CERN, Paul Scherrer Institute

Swiss Nanoscience Institute

The Swiss Nanoscience Institute is a multidisciplinary research institute located in Porrentruy, Canton of Jura, Switzerland that coordinates nanoscience research, education, and technology transfer across Swiss and international partners such as University of Basel, ETH Zurich, EPFL, Paul Scherrer Institute, and CERN. It supports basic and applied projects spanning collaborations with entities like IBM, Siemens, Novartis, Roche, and academic centers such as École Polytechnique, Max Planck Society, CNRS, Imperial College London, and Harvard University. The institute operates facilities and training programs that connect regional stakeholders including Canton of Jura authorities, Swiss National Science Foundation, and European initiatives such as Horizon 2020 and Horizon Europe.

History

Founded in 2001 with support from the Canton of Jura and university partners including University of Basel and ETH Zurich, the institute emerged amid European nanotechnology policy initiatives like European Technology Platform on Nanomedicine and national efforts coordinated by the Swiss National Science Foundation and Innosuisse. Early milestones involved partnerships with industrial leaders such as Novartis and Roche and research exchanges with institutes like Paul Scherrer Institute and Max Planck Society. During the 2000s the institute expanded its remit through programs linked to Horizon 2020, collaborations with EPFL and Imperial College London, and joint projects with CERN and IBM. Subsequent decades saw growth in education aligned with universities such as University of Basel, strengthened technology transfer with Innosuisse and Swiss Innovation Park, and regional development tied to Canton of Jura initiatives.

Mission and Research Focus

The institute's mission emphasizes translational nanoscience bridging partners including University of Basel, ETH Zurich, EPFL, Paul Scherrer Institute, Max Planck Society, and industry actors such as Siemens, IBM, Novartis, and Roche to address challenges in areas linked to nanomedicine, quantum technologies, and advanced materials. Research themes include quantum devices influenced by initiatives at CERN and IBM, biomaterials and drug delivery connected to Novartis and Roche, and nanoscale metrology allied with Paul Scherrer Institute and ETH Zurich. The institute pursues innovation pathways aligned with funding sources like Swiss National Science Foundation, Innosuisse, and European programs such as Horizon Europe and ERC grants.

Organization and Governance

Governance integrates representatives from academic partners including University of Basel, ETH Zurich, EPFL, and Paul Scherrer Institute alongside regional authorities from Canton of Jura and funding organizations such as Swiss National Science Foundation and Innosuisse. The leadership model parallels governance structures seen at Max Planck Society institutes and national laboratories like Paul Scherrer Institute, with advisory boards comprising academics from Imperial College London, Harvard University, École Polytechnique, and industrial stakeholders from Novartis and Roche. Operational units coordinate with university departments at University of Basel and ETH Zurich and maintain links to infrastructure programs such as Swiss Innovation Park and European consortia funded by Horizon Europe.

Facilities and Laboratories

Facilities include cleanrooms, characterization suites, and nanofabrication labs developed in cooperation with partners like Paul Scherrer Institute, ETH Zurich, EPFL, and University of Basel, and supported by equipment vendors and industrial collaborators such as IBM and Siemens. The institute hosts instrumentation for electron microscopy related to Max Planck Society capabilities, scanning probe techniques aligned with CERN instrumentation knowledge, spectroscopy platforms reflecting methods used at Paul Scherrer Institute, and bio-nanotechnology labs collaborating with Novartis and Roche. Shared infrastructure arrangements mirror consortia models between EPFL, ETH Zurich, and national facilities funded through programs like Horizon 2020.

Education and Training Programs

Training programs provide graduate and postgraduate tracks in partnership with University of Basel, ETH Zurich, EPFL, and international universities such as Imperial College London, Harvard University, École Polytechnique, and Max Planck Society research schools. The institute offers doctoral supervision linking to doctoral programs at University of Basel and collaborative PhD initiatives supported by Swiss National Science Foundation and European Research Council grants, plus industry internships with companies including Novartis, Roche, IBM, and Siemens. Outreach and continuing education engage regional entities like Canton of Jura and engage European networks funded under Horizon Europe and professional societies such as IEEE and Royal Society collaborations.

Collaborations and Industry Partnerships

Collaborations span academic partners including University of Basel, ETH Zurich, EPFL, Max Planck Society, Paul Scherrer Institute, and Imperial College London, and industrial partners such as Novartis, Roche, IBM, Siemens, and Philips. The institute participates in European consortia under Horizon 2020 and Horizon Europe and hosts joint projects with international laboratories like CERN and CNRS. Technology transfer pathways involve Innosuisse, Swiss Innovation Park, and venture partnerships connecting to investors and incubators linked to ETH Zurich and EPFL spin-off ecosystems.

Notable Projects and Achievements

Notable achievements include collaborative advances in quantum device research aligned with efforts at IBM and CERN, biomaterials and drug-delivery platforms co-developed with Novartis and Roche, and instrumentation methods improved in tandem with Paul Scherrer Institute and ETH Zurich. Projects funded through Swiss National Science Foundation, ERC awards, and European programs like Horizon Europe have produced peer-reviewed outputs and spin-offs connected to University of Basel and EPFL incubators. The institute's role in regional innovation contributed to economic and scientific development in the Canton of Jura, and its networks with Max Planck Society, Imperial College London, Harvard University, and industry partners have underpinned high-impact translational research.

Category:Nanotechnology